Patent details

Basic Information

Publication number:

EP3525825

PCT Application Number:

IN2017050468

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP177977642

PCT Publication Number:

WO2018069938

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES COMPRENANT DE LA RIFAXIMINE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT RIFAXIMIN

SPC Number:

Dates

Filing date:

13/10/2017

Grant date:

20/03/2024

EP Publication Date:

21/08/2019

PCT Publication Date:

19/04/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/03/2024

EP B1 Publication Date:

20/03/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/10/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/03/2024

 

 

Name:

Cipla Limited

Address:

Cipla House Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra 400013, India (IN)

Inventor

1

Name:

JOSHI, Kalpana

Address:

India (IN)

2

Name:

MALHOTRA, Geena

Address:

India (IN)

3

Name:

GHOSALKAR, Jeevan

Address:

India (IN)

Priority

Priority Number:

201621035173

Priority Date:

14/10/2016

Priority Country:

India (IN)

Classification

IPC classification:

A61K 47/22; A61K 31/437; A61K 31/4525; A61K 9/20; A61K 9/48;

Publication

European Patent Bulletin

Issue number:

202412

Publication date:

20/03/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/04/2025

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages